ArticleBritish journal of cancer2024

Aberrant activation of AXL may drive progression of squamous cell carcinoma in CLL patients: a mechanistic study with clinical implications.

Sutapa Sinha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.